Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
The company also reported significant progress toward its internally defined Sustainable Development Goals
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
Subscribe To Our Newsletter & Stay Updated
